# Clinical trials recruiting in Ohio: 3,366 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 3,366 trials recruiting or not yet recruiting with a site in Ohio, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Ohio: 3,366 rows for $113.66, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 51 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/ohio

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 3,366
- Recruiting or not yet: 3,366
- Read on: November 19, 2026

## Trials

The 25 newest of 3,366, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07946601 | Genomic ctDNA-Informed De-escalation And Neoadjuvant Chemotherapy Omission in Cystectomy | Case Comprehensive Cancer Center | Phase 2 | Not yet recruiting | Muscle Invasive Bladder Cancer (MIBC) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946601) |
| November 18, 2026 | NCT07945730 | How a Ketogenic Diet Affects Hormones and Metabolism in Women | Ohio State University | Not applicable | Recruiting | Menstrual Cycle, Premenopausal | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945730) |
| November 18, 2026 | NCT07945704 | GLP-1 RAs and Dietary Intake and Body Composition | Ohio University | Observational | Recruiting | Glucagon-Like Peptide-1 Receptor Agonists, Metabolism, Body Composition | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945704) |
| November 17, 2026 | NCT07942636 | EMST 150 Training in Mild-Moderate OSA | University Hospitals Cleveland Medical Center | Not applicable | Not yet recruiting | Obstructive Sleep Apnea | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942636) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 16, 2026 | NCT07937982 | Protocol CAUSE-05 RHINO | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Not yet recruiting | Asthma, Respiratory Health | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937982) |
| November 13, 2026 | NCT07936201 | Study of LusPACercept in Participants With Myelofibrosis Associated Anemia and Thrombocytopenia | Case Comprehensive Cancer Center | Phase 2 | Not yet recruiting | Myelofibrosis | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07936201) |
| November 13, 2026 | NCT07935317 | A Study of Tersolisib (LY4064809) and Abemaciclib With Hormone Therapies in Participants With PIK3CA-Mutated Early Breast Cancer | Eli Lilly and Company | Phase 2 | Not yet recruiting | Breast Neoplasms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935317) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931170 | Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study | Pediatric Nephrology Research Consortium | Observational | Recruiting | IgA Nephropathy (IgAN), IgA Vasculitis, Idiopathic Immune Complex Glomerulonephritis, C3 Glomerulopathy, Membranous... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931170) |
| November 12, 2026 | NCT07930806 | Stryker Photon Blade 3 Outcomes | The Cleveland Clinic | Observational | Not yet recruiting | Lumpectomy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930806) |
| November 10, 2026 | NCT07929922 | Arthrocentesis vs Observation Study for Acute ACL Tears | Ohio State University | Not applicable | Recruiting | Anterior Cruciate Ligament (ACL) Tear | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929922) |
| November 10, 2026 | NCT07928986 | A Multi Center Evaluation of TearCare on Surgical Measurements Before Cataract Surgery | Cleveland Eye Clinic | Observational | Recruiting | Dry Eye Syndrome (DES), Meibomian Gland Dysfunction (Disorder) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928986) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 10, 2026 | NCT07928089 | Mechanisms Within the Autonomic Nervous SysTEm undeRlying MusIc Therapy's aNalgesic Effects in Sickle Cell Disease (MASTERMIND) | University Hospitals Cleveland Medical Center | Not applicable | Not yet recruiting | Sickle Cell Disease | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928089) |
| November 10, 2026 | NCT07927413 | Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients | Corza Medical GmbH | Observational | Recruiting | Cerebrospinal Fluid (CSF) Leak, Psuedomeningocele | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927413) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07919392 | Restoring Emotional Needs With Exogenous Ketones for Women With Postpartum Depression | Ohio State University | Not applicable | Recruiting | Postpartum Depression (PPD) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919392) |
| November 4, 2026 | NCT07917598 | TEA Synchronized With Natural Breathing for EPS | MetroHealth Medical Center | Phase 1 | Not yet recruiting | Epigastric Pain Syndrome | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917598) |
| November 4, 2026 | NCT07917208 | Early Feasibility Study of the Capstan Medical TMVR System | Capstan Medical | Not applicable | Recruiting | Mitral Regurgitation (MR) | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917208) |
| November 4, 2026 | NCT07915700 | Hand Prosthesis Usability and Performance | Össur Iceland ehf | Not applicable | Recruiting | Amputation | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915700) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Cleveland Clinic | Cleveland | 363 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | 267 |
| Ohio State University Comprehensive Cancer Center | Columbus | 254 |
| Nationwide Children's Hospital | Columbus | 187 |
| University Hospitals Cleveland Medical Center | Cleveland | 175 |
| Cleveland Clinic Foundation | Cleveland | 151 |
| The Ohio State University | Columbus | 143 |
| Ohio State University | Columbus | 137 |
| University of Cincinnati | Cincinnati | 102 |
| Case Western Reserve University | Cleveland | 84 |
| University of Cincinnati Medical Center | Cincinnati | 81 |
| The Ohio State University Wexner Medical Center | Columbus | 81 |
| Miami Valley Hospital South | Centerville | 72 |
| Miami Valley Hospital North | Dayton | 56 |
| Miami Valley Hospital | Dayton | 55 |
| Atrium Medical Center-Middletown Regional Hospital | Franklin | 54 |
| Upper Valley Medical Center | Troy | 54 |
| University of Cincinnati Cancer Center-UC Medical Center | Cincinnati | 50 |
| University of Cincinnati Cancer Center-West Chester | West Chester | 49 |
| The Christ Hospital | Cincinnati | 47 |
| Kettering Medical Center | Kettering | 43 |
| Cincinnati Children's Hospital | Cincinnati | 42 |
| Miami Valley Cancer Care and Infusion | Greenville | 42 |
| Good Samaritan Hospital - Cincinnati | Cincinnati | 42 |
| Bethesda North Hospital | Cincinnati | 41 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 29 |
| Phase 1 | 276 |
| Phase 1/2 | 238 |
| Phase 2 | 583 |
| Phase 2/3 | 86 |
| Phase 3 | 739 |
| Phase 4 | 113 |
| Not applicable | 756 |
| Observational | 546 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 138 |
| Breast Neoplasms | 94 |
| Neoplasms | 93 |
| Lung Neoplasms | 73 |
| Prostatic Neoplasms | 69 |
| Neoplasm Metastasis | 67 |
| Colorectal Neoplasms | 64 |
| Ovarian Neoplasms | 64 |
| Leukemia, Myeloid, Acute | 63 |
| Endometrial Neoplasms | 59 |
| Heart Failure | 57 |
| Recurrence | 54 |
| Obesity | 52 |
| Multiple Myeloma | 50 |
| Squamous Cell Carcinoma of Head and Neck | 49 |
| Diabetes Mellitus, Type 2 | 48 |
| Pancreatic Neoplasms | 47 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 46 |
| Melanoma | 45 |
| Lymphoma, Non-Hodgkin | 40 |
| Urinary Bladder Neoplasms | 39 |
| Overweight | 38 |
| Cardiovascular Diseases | 36 |
| Stroke | 36 |
| Lymphoma | 34 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ohio State University | 134 |
| Children's Hospital Medical Center, Cincinnati | 102 |
| The Cleveland Clinic | 98 |
| National Cancer Institute (NCI) | 96 |
| Ohio State University Comprehensive Cancer Center | 81 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 73 |
| Case Comprehensive Cancer Center | 58 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 55 |
| University Hospitals Cleveland Medical Center | 44 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 43 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 40 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 39 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 38 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 34 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 34 |
| University of Cincinnati | 32 |
| VA Office of Research and Development | 31 |
| Nationwide Children's Hospital | 30 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 28 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 28 |
| Children's Oncology Group | 27 |
| SWOG Cancer Research Network | 25 |
| Case Western Reserve University | 25 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 25 |
| Alliance for Clinical Trials in Oncology | 24 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Ohio

- [Deck builders in Ohio, United States](https://specstream.ai/data/businesses/deck-builders/ohio-united-states)
- [Freight and cargo companies in Ohio, United States](https://specstream.ai/data/businesses/freight-and-cargo-companies/ohio-united-states)
- [Korean restaurants in Ohio, United States](https://specstream.ai/data/businesses/korean-restaurants/ohio-united-states)
- [Packing services in Ohio, United States](https://specstream.ai/data/businesses/packing-services/ohio-united-states)
- [Salad bars in Ohio, United States](https://specstream.ai/data/businesses/salad-bars/ohio-united-states)
- [Vietnamese restaurants in Ohio, United States](https://specstream.ai/data/businesses/vietnamese-restaurants/ohio-united-states)
